SOCS7 Antibody Cat

Total Page：16

File Type：pdf, Size：1020Kb

SOCS7 Antibody Cat. No.: 58-953 SOCS7 Antibody Specifications HOST SPECIES: Rabbit SPECIES REACTIVITY: Human HOMOLOGY: Predicted species reactivity based on immunogen sequence: Mouse This SOCS7 antibody is generated from rabbits immunized with a KLH conjugated IMMUNOGEN: synthetic peptide between 458-486 amino acids from the C-terminal region of human SOCS7. TESTED APPLICATIONS: WB APPLICATIONS: For WB starting dilution is: 1:1000 PREDICTED MOLECULAR 63 kDa WEIGHT: Properties This antibody is purified through a protein A column, followed by peptide affinity PURIFICATION: purification. CLONALITY: Polyclonal ISOTYPE: Rabbit Ig October 2, 2021 1 https://www.prosci-inc.com/socs7-antibody-58-953.html CONJUGATE: Unconjugated PHYSICAL STATE: Liquid BUFFER: Supplied in PBS with 0.09% (W/V) sodium azide. CONCENTRATION: batch dependent Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies STORAGE CONDITIONS: care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures. Additional Info OFFICIAL SYMBOL: SOCS7 Suppressor of cytokine signaling 7, SOCS-7, Nck, Ash and phospholipase C gamma-binding ALTERNATE NAMES: protein, Nck-associated protein 4, NAP-4, SOCS7, NAP4, SOCS6 ACCESSION NO.: O14512 GENE ID: 30837 USER NOTE: Optimal dilutions for each application to be determined by the researcher. Background and References Regulates signaling cascades probably through protein ubiquitination and/or sequestration. Functions in insulin signaling and glucose homeostasis through IRS1 ubiquitination and subsequent proteasomal degradation. Inhibits also prolactin, growth BACKGROUND: hormone and leptin signaling by preventing STAT3 and STAT5 activation, sequestering them in the cytoplasm and reducing their binding to DNA. May be a substrate recognition component of a SCF-like E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins (By similarity). REFERENCES: 1) Pazienza, V., et al. J. Gen. Virol. 91 (PT 7), 1678-1686 (2010) : 2) Sasi, W., et al. BMC Cancer 10, 178 (2010) : 3) Kremer, B.E., et al. Cell 130(5):837-850(2007) 4) Zody, M.C., et al. Nature 440(7087):1045-1049(2006) ANTIBODIES FOR RESEARCH USE ONLY. For additional information, visit ProSci's Terms & Conditions Page. October 2, 2021 2 https://www.prosci-inc.com/socs7-antibody-58-953.html.

Copy Link

Recommended publications

A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
[Show full text]
Expression of SOCS1 and SOCS3 Genes Is Differentially Regulated in Breast Cancer Cells in Response to Proinﬂammatory Cytokine and Growth Factor Signals
Oncogene (2007) 26, 1941–1948 & 2007 Nature Publishing Group All rights reserved 0950-9232/07 $30.00 www.nature.com/onc ORIGINAL ARTICLE Expression of SOCS1 and SOCS3 genes is differentially regulated in breast cancer cells in response to proinﬂammatory cytokine and growth factor signals MK Evans1, C-R Yu2, A Lohani1, RM Mahdi2, X Liu2, AR Trzeciak1 and CE Egwuagu2 1Laboratory of Cellular and Molecular Biology, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA and 2Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD, USA DNA-hypermethylation of SOCS genes in breast, ova- Keywords: breast-cancer cells; SOCS; breast cancer; STAT; rian, squamous cell and hepatocellular carcinoma has led BRCA1; DNA hypermethylation; interferon to speculation that silencing of SOCS1 and SOCS3 genes might promote oncogenic transformation of epithelial tissues. To examine whether transcriptional silencing of SOCS genes is a common feature of human carcinoma, we have investigated regulation of SOCS genes expression by Introduction IFNc, IGF-1 and ionizing radiation, in a normal human mammary epithelial cell line (AG11134), two breast- Development of the mammary gland is regulated by cancer cell lines (MCF-7, HCC1937) and three prostate factors that coordinate proliferation, differentiation, cancer cell lines. Compared to normal breast cells, we maturation and apoptosis of mammary epithelial cells. observe a high level constitutive expression of SOCS2, Exquisite control of the initiation, strength and duration SOCS3, SOCS5, SOCS6, SOCS7, CIS and/or SOCS1 of signals from the diverse array of cytokines and genes in the human cancer cells. In MCF-7 and HCC1937 growth factors in mammalian breast is essential to the breast-cancer cells, transcription of SOCS1 is dramati- timely initiation of the menstrual cycle, lactation or cally up-regulated by IFNc and/or ionizing-radiation breast lobule involution (Medina, 2005).
[Show full text]
Structural Insights Into Substrate Recognition by the SOCS2 E3 Ubiquitin Ligase
bioRxiv preprint doi: https://doi.org/10.1101/470187; this version posted March 15, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Title 2 Structural insights into substrate recognition by the SOCS2 E3 ubiquitin ligase 3 4 Authors 5 Wei-Wei Kung*, Sarath Ramachandran*, Nikolai Makukhin*, Elvira Bruno, Alessio Ciulli 6 *These authors contributed equally to this work 7 8 Address 9 Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of 10 Dundee, James Black Centre, Dow Street, Dundee, DD1 5EH, United Kingdom 11 12 Abstract 13 The suppressor of cytokine signaling 2 (SOCS2) acts as substrate recognition subunit of a 14 Cullin5 E3 ubiquitin ligase complex. SOCS2 binds to phosphotyrosine-modified epitopes 15 as degrons for ubiquitination and proteasomal degradation, yet the molecular basis of 16 substrate recognition has remained elusive. We solved co-crystal structures of SOCS2- 17 ElonginB-ElonginC in complex with phosphorylated peptides from substrates growth 18 hormone receptor (GHR-pY595) and erythropoietin receptor (EpoR-pY426) at 1.98 Å and 19 2.69 Å, respectively. Both peptides bind in an extended conformation recapitulating the 20 canonical SH2 domain-pY pose, yet capture different conformations of the EF loop via 21 specific hydrophobic interactions. The flexible BG loop, for the first time fully defined in the 22 electron density, does not contact the substrate degrons directly. Cancer-associated SNPs 23 located around the pY pocket weaken substrate-binding affinity in biophysical assays.
[Show full text]
The Emerging Role of Suppressors of Cytokine Signaling (SOCS) in the Development and Progression of Leukemia
cancers Review The Emerging Role of Suppressors of Cytokine Signaling (SOCS) in the Development and Progression of Leukemia Esra’a Keewan 1,2 and Ksenia Matlawska-Wasowska 1,2,* 1 Department of Pediatrics, Division of Hematology and Oncology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA; [email protected] 2 Comprehensive Cancer Center, University of New Mexico, Albuquerque, NM 87131, USA * Correspondence: [email protected]; Tel.: +1-505-272-6177 Simple Summary: The suppressors of cytokine signaling (SOCS) are known cytokine-inducible negative regulators of JAK/STAT and other cell signaling pathways. Deregulation of SOCS expression is linked to various tumor types and inﬂammatory diseases. While SOCS play a crucial role in the regulation of immune cell function, their roles in hematological malignancies have not been elucidated thus far. In this review, we summarize the current knowledge on the roles of SOCS in leukemia development and progression. We delineate the paradoxical activities of SOCS in different leukemia types and the regulatory mechanisms underlying SOCS deregulation in leukemia. Lastly, we discuss the possible implications of SOCS deregulation for leukemia diagnosis and prognosis. This paper provides new insights into the roles of SOCS in the pathobiology of leukemia and leukemia research. Abstract: Cytokines are pleiotropic signaling molecules that execute an essential role in cell-to-cell communication through binding to cell surface receptors. Receptor binding activates intracellular Citation: Keewan, E.; signaling cascades in the target cell that bring about a wide range of cellular responses, including Matlawska-Wasowska, K. The induction of cell proliferation, migration, differentiation, and apoptosis.
[Show full text]
Potential Implications for SOCS in Chronic Wound Healing
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 38: 1349-1358, 2016 Expression of the SOCS family in human chronic wound tissues: Potential implications for SOCS in chronic wound healing YI FENG1, ANDREW J. SANDERS1, FIONA RUGE1,2, CERI-ANN MORRIS2, KEITH G. HARDING2 and WEN G. JIANG1 1Cardiff China Medical Research Collaborative and 2Wound Healing Research Unit, Cardiff University School of Medicine, Cardiff University, Cardiff CF14 4XN, UK Received April 12, 2016; Accepted August 2, 2016 DOI: 10.3892/ijmm.2016.2733 Abstract. Cytokines play important roles in the wound an imbalance between proteinases and their inhibitors, and healing process through various signalling pathways. The the presence of senescent cells is of importance in chronic JAK-STAT pathway is utilised by most cytokines for signal wounds (1). A variety of treatments, such as dressings, appli- transduction and is regulated by a variety of molecules, cation of topical growth factors, autologous skin grafting and including suppressor of cytokine signalling (SOCS) proteins. bioengineered skin equivalents have been applied to deal SOCS are associated with inflammatory diseases and have with certain types of chronic wounds in addition to the basic an impact on cytokines, growth factors and key cell types treatments (1). However, the specific mechanisms of each trea- involved in the wound-healing process. SOCS, a negative ment remain unclear and are under investigation. Therefore, regulator of cytokine signalling, may hold the potential more insight into the mechanisms responsible are required to regulate cytokine-induced signalling in the chronic to gain a better understanding of the wound-healing process. wound-healing process. Wound edge tissues were collected Further clarification of this complex system may contribute to from chronic venous leg ulcer patients and classified as non- the emergence of a prognositc marker to predict the healing healing and healing wounds.
[Show full text]
Negative Regulation of Cytokine Signaling in Immunity
Downloaded from http://cshperspectives.cshlp.org/ on September 27, 2021 - Published by Cold Spring Harbor Laboratory Press Negative Regulation of Cytokine Signaling in Immunity Akihiko Yoshimura, Minako Ito, Shunsuke Chikuma, Takashi Akanuma, and Hiroko Nakatsukasa Department of Microbiology and Immunology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan Correspondence: [email protected] Cytokines are key modulators of immunity. Most cytokines use the Janus kinase and signal transducers and activators of transcription (JAK-STAT) pathway to promote gene tran- scriptional regulation, but their signals must be attenuated by multiple mechanisms. These include the suppressors of cytokine signaling (SOCS) family of proteins, which represent a main negative regulation mechanism for the JAK-STAT pathway. Cytokine-inducible Src homology 2 (SH2)-containing protein (CIS), SOCS1, and SOCS3 proteins regulate cytokine signals that control the polarization of CD4þ T cells and the maturation of CD8þ T cells. SOCS proteins also regulate innate immune cells and are involved in tumorigenesis. This review summarizes recent progress on CIS, SOCS1, and SOCS3 in T cells and tumor immunity. here are four types of the cytokine receptors: (ERK) pathway (see Fig. 1). Any receptor that T(1) receptors that activate nuclear factor activates intracellular signaling pathways has (NF)-kB and mitogen-activated protein (MAP) multiple negative feedback systems, which en- kinases (mainly p38 and c-Jun amino-terminal sures transient activation of the pathway and kinase [JNK]), such as receptors for the tumor downstream transcription factors. Typical neg- necrosis factor (TNF)-a family, the interleukin ative regulators are shown in Figure 1. Lack of (IL)-1 family, including IL-1b, IL-18, and IL- such negative regulators results in autoimmune 33, and the IL-17 family; (2) receptors that diseases, autoinﬂammatory diseases, and some- activate the Janus kinase and signal transducers times-fatal disorders, including cancer.
[Show full text]
The Role of Suppressor of Cytokine Signaling 1 and 3 in Human Cytomegalovirus Replication
Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2012 The Role of Suppressor of Cytokine Signaling 1 and 3 in Human Cytomegalovirus Replication Sonzogni, O Posted at the Zurich Open Repository and Archive, University of Zurich ZORA URL: https://doi.org/10.5167/uzh-71661 Dissertation Published Version Originally published at: Sonzogni, O. The Role of Suppressor of Cytokine Signaling 1 and 3 in Human Cytomegalovirus Replica- tion. 2012, University of Zurich, Faculty of Science. The Role of Suppressor of Cytokine Signaling 1 and 3 in Human Cytomegalovirus Replication Dissertation zur Erlangung der naturwissenschaftlichen Doktorwürde (Dr. sc. nat.) vorgelegt der Mathematisch-naturwissenschaftlichen Fakultät der Universität Zürich von Olmo Sonzogni von Moleno, TI Promotionskomitee: Prof. Dr. Nicolas J. Müller (Leitung der Dissertation) Prof. Dr. Christoph Renner (Vorsitz) Prof. Dr. Amedeo Caflisch Zürich, 2012 To my parents Dissertation Table of contents 1. Summary......................................................................................................................9 2. Zusammenfassung ...................................................................................................11 3. Introduction ...............................................................................................................13 3.1 Human cytomegalovirus .........................................................................................13 3.1.1 Epidemiology and
[Show full text]
4832.Full.Pdf
IFN-α-Induced Signal Transduction, Gene Expression, and Antitumor Activity of Immune Effector Cells Are Negatively Regulated by Suppressor of Cytokine This information is current as Signaling Proteins of September 24, 2021. Jason M. Zimmerer, Gregory B. Lesinski, Sri Vidya Kondadasula, Volodymyr I. Karpa, Amy Lehman, Abhik RayChaudhury, Brian Becknell and William E. Carson III J Immunol 2007; 178:4832-4845; ; Downloaded from doi: 10.4049/jimmunol.178.8.4832 http://www.jimmunol.org/content/178/8/4832 http://www.jimmunol.org/ References This article cites 65 articles, 29 of which you can access for free at: http://www.jimmunol.org/content/178/8/4832.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 24, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2007 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology IFN-␣-Induced Signal Transduction, Gene Expression, and Antitumor Activity of Immune Effector Cells Are Negatively Regulated by Suppressor of Cytokine Signaling Proteins1 Jason M.
[Show full text]
SOCS) Gene Family in Vertebrates Bei Wang,1,2 Eakapol Wangkahart,2,3 Christopher J
Insights into the Evolution of the Suppressors of Cytokine Signaling (SOCS) Gene Family in Vertebrates Bei Wang,1,2 Eakapol Wangkahart,2,3 Christopher J. Secombes,2 and Tiehui Wang*,2 1Guangdong Provincial Key Laboratory of Pathogenic Biology and Epidemiology for Aquatic Economic Animal, Key Laboratory of Control for Disease of Aquatic Animals of Guangdong Higher Education Institutes, College of Fishery, Guangdong Ocean University, Zhanjiang, P.R. China 2Scottish Fish Immunology Research Centre, Institute of Biological and Environmental Sciences, University of Aberdeen, Aberdeen, United Kingdom 3Research Unit of Excellence for Tropical Fisheries and Technology, Division of Fisheries, Department of Agricultural Technology, Faculty of Technology, Mahasarakham University, Khamriang Sub-District, Kantarawichai, Mahasarakham, Thailand *Corresponding author: E-mail: [email protected]. Associate editor: Yoko Satta Abstract TheSOCSfamilyarekeynegativeregulatorsofcytokineandgrowth factor signaling. Typically, 8–17 SOCS genes are present in vertebrate species with eight known in mammals, classified as type I (SOCS4–7) and type II (CISH and SOCS1–3) SOCS. It was believed that the type II SOCS were expanded through the two rounds of whole genome duplication (1R and 2R WGDs) from a single CISH/SOCS1–3 precursor. Previously, 12 genes were identified in rainbow trout but here we report 15 additional loci are present, and confirm 26 of the genes are expressed, giving rainbow trout the largest SOCS gene repertoire identified to date. The discovery of the additional SOCS genes in trout has led to a novel model of SOCS family evolution, whereby the vertebrate SOCS gene family was derived from CISH/SOCS2, SOCS1/SOCS3, SOCS4/5, SOCS6, and SOCS7 ancestors likely present before the two WGD events.
[Show full text]
Control of Tyrosine Kinase Signalling by Small Adaptors in Colorectal Cancer
cancers Review Control of Tyrosine Kinase Signalling by Small Adaptors in Colorectal Cancer Rudy Mevizou, Audrey Sirvent and Serge Roche * CRBM, CNRS, Univ. Montpellier, “Equipe labellisée Ligue Contre le Cancer”, F-34000 Montpellier, France; [email protected] (R.M.); [email protected] (A.S.) * Correspondence: [email protected] Received: 24 April 2019; Accepted: 12 May 2019; Published: 14 May 2019 Abstract: Tyrosine kinases (TKs) phosphorylate proteins on tyrosine residues as an intracellular signalling mechanism to coordinate intestinal epithelial cell communication and fate decision. Deregulation of their activity is ultimately connected with carcinogenesis. In colorectal cancer (CRC), it is still unclear how aberrant TK activities contribute to tumour formation because TK-encoding genes are not frequently mutated in this cancer. In vertebrates, several TKs are under the control of small adaptor proteins with potential important physiopathological roles. For instance, they can exert tumour suppressor functions in human cancer by targeting several components of the oncogenic TK signalling cascades. Here, we review how the Src-like adaptor protein (SLAP) and the suppressor of cytokine signalling (SOCS) adaptor proteins regulate the SRC and the Janus kinase (JAK) oncogenic pathways, respectively, and how their loss of function in the intestinal epithelium may inﬂuence tumour formation. We also discuss the potential therapeutic value of these adaptors in CRC. Keywords: cell signalling; tyrosine kinase; small adaptor proteins; colorectal cancer; targeted therapy 1. Colorectal Cancer Colorectal cancer (CRC) is one of the leading causes of malignancy-related death worldwide. Most of these cancers are sporadic and under the control of genetic, epigenetic and environmental factors.
[Show full text]
Identification of the Presence and Activity of the JAK-STAT Pathway In
Identification of the Presence and Activity of the JAK-STAT Pathway in Canine Tumors Erin A. Fagan Thesis submitted to the faculty of the Virginia Polytechnic Institute and State University in partial fulfillment of the requirements for the degree of Master of Science In Biomedical and Veterinary Sciences Nikolaos Dervisis Shawna Klahn Tanya LeRoith April 13th 2017 Keywords: JAK-STAT, canine, hemangiosarcoma, mast cell tumor, thyroid carcinoma, apocrine gland anal sac adenocarcinoma, neoplasia ABSTRACT (Academic) Background: The JAK-STAT pathway is a cellular signaling pathway, which acts normally in humans and animals in the control of multiple important functions. Dysregulation of this pathway has been identified in human cancers, as well as a limited number of veterinary cancers. Objectives: The aims of this study were to identify the presence and tentative activity of components of the JAK-STAT pathway in selected canine tumors. Methods: Formalin-fixed, paraffin-embedded samples from mast cell tumors (MCT), hemangiosarcomas (HSA), thyroid carcinomas, and apocrine gland anal sac adenocarcinomas (AGASACA) were obtained from the Diagnostic Histopathology Laboratory at the Virginia Maryland College of Veterinary Medicine. Immunohistochemistry was performed to evaluate protein levels of JAK1, phospho-JAK1, JAK2, phospho-JAK2, STAT3, and phospho-STAT3. Signalment, treatment information, and survival information was obtained from the medical record for each case. Results: Tumor samples were scored for percent positive neoplastic cells. Positive staining was seen for all antibodies in all tumor types, with expression of JAK1, STAT3, and pSTAT3 being highest overall for all tumor types. Significant associations were seen between JAK1 and survival time in MCT (p = 0.03), pJAK1 and survival time in HSA (p = 0.009) and MCT (p = 0.04), and pSTAT3 and metastasis in MCT (p = 0.0008).
[Show full text]
Differential Induction of SOCS Isoforms by Leishmania Donovani Impairs Macrophage−T Cell Cross-Talk and Host Defense
Differential Induction of SOCS Isoforms by Leishmania donovani Impairs Macrophage−T Cell Cross-Talk and Host Defense This information is current as Pragya Chandrakar, Naveen Parmar, Albert Descoteaux and of September 30, 2021. Susanta Kar J Immunol published online 27 December 2019 http://www.jimmunol.org/content/early/2019/12/26/jimmun ol.1900412 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2019/12/26/jimmunol.190041 Material 2.DCSupplemental http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 30, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2019 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published December 27, 2019, doi:10.4049/jimmunol.1900412 The Journal of Immunology Differential Induction of SOCS Isoforms by Leishmania donovani Impairs Macrophage–T Cell Cross-Talk and Host Defense Pragya Chandrakar,*,† Naveen Parmar,*,† Albert Descoteaux,‡ and Susanta Kar*,† Immune evasion strategies adopted by Leishmania donovani involve the exploitation of suppressor of cytokine signaling (SOCS) proteins that are well-known negative regulators of the JAK/STAT pathway.
[Show full text]